Clearside Biomedical Historical Earnings image   This CLSD historical earnings page last updated 11/28/2025
Clearside Biomedical Historical Revenue
PeriodHistorical Earnings DateGAAP
Q3 202511/14/20250.00B
Q2 20258/8/20250.00B
Q1 20255/14/20250.00B
Q4 20243/27/20250.00B
Q3 202411/12/20240.00B
Q2 20248/12/20240.09M
Q1 20245/9/20240.00B
Q4 20233/12/20240.01B
Q3 202311/13/20230.00B
Q2 20238/14/20230.00B
Q1 20235/11/20230.00M
Q4 20223/9/20230.00B
Q3 202211/9/20220.00B
Q2 20228/9/20220.00B
Q1 20225/11/20220.00B
Q4 20213/10/20220.03B
Q3 202111/10/20210.00B
Q2 20218/10/20210.00B
Q1 20215/17/20210.03M
Q4 20203/10/20210.01M
Q3 202011/10/20200.00B
Q2 20208/10/20200.00B
Q1 20205/8/20200.00B
Q4 20193/11/20200.00B
Q3 201911/6/20190.00B
Q2 20198/7/20190.04M
Q1 20195/8/20190.04M
Q4 20183/12/201930000
Q3 201811/8/2018NA
Q2 20188/8/2018NA
Q1 20185/9/2018NA
Q4 20173/14/201855000
Q3 201711/8/2017155000
Q2 20178/9/2017130000
Q1 20175/10/20175000
Q4 20163/14/20175000
Q3 201611/9/20165000
Q2 20168/11/20165000
Clearside Biomedical Historical Earnings EPS
PeriodHistorical Earnings DateGAAP
Q3 202511/14/2025-1.140
Q2 20258/8/2025-0.900
Q1 20255/14/2025-1.650
Q4 20243/27/2025-1.500
Q3 202411/12/2024-1.500
Q2 20248/12/2024-1.500
Q1 20245/9/2024-2.550
Q4 20233/12/2024-1.200
Q3 202311/13/2023-2.250
Q2 20238/14/2023-2.250
Q1 20235/11/2023-2.250
Q4 20223/9/2023-2.400
Q3 202211/9/2022-1.950
Q2 20228/9/2022-1.950
Q1 20225/11/2022-1.950
Q4 20213/10/20224.650
Q3 202111/10/2021-1.200
Q2 20218/10/2021-1.650
Q1 20215/17/2021-1.950
Q4 20203/10/2021-2.100
Q3 202011/10/2020-0.750
Q2 20208/10/2020-1.950
Q1 20205/8/2020-2.550
Q4 20193/11/2020-1.050
Q3 201911/6/2019-2.550
Q2 20198/7/2019-2.250
Q1 20195/8/2019-6.750
Q4 20183/12/2019-10.200
Q3 201811/8/2018-11.250
Q2 20188/8/2018-9.750
Q1 20185/9/2018-9.300
Q4 20173/14/2018-9.750
Q3 201711/8/2017-10.800
Q2 20178/9/2017-8.100
Q1 20175/10/2017-6.150
Q4 20163/14/2017-6.750
Q3 201611/9/2016-4.200
Q2 20168/11/2016-9.300
Quotes delayed 20 minutes

Email EnvelopeFree CLSD Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Clearside Biomedical (CLSD) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

CLSN Historical Earnings
CLVS Historical Earnings
CLXT Historical Earnings
CLYM Historical Earnings
CMAX Historical Earnings
CMD Historical Earnings
CMPI Historical Earnings
CMPX Historical Earnings
CMRX Historical Earnings
CNC Historical Earnings
What was the record high CLSD historical earnings result?
In terms of earnings or revenue, what is the best CLSD historical earnings result that Clearside Biomedical has ever posted, and when?

✔️Accepted answer: Within our data set, the highest CLSD historical earnings result was set in Q4 2021, when Clearside Biomedical posted results of 4.650/share. The most successful revenue quarter within our data set was Q4 2021 when Clearside Biomedical reported revenue of 0.03B.

What was the lowest Clearside Biomedical historical earnings result?
In terms of top line revenue or bottom line earnings per share, what was the lowest CLSD has reported, and when?

✔️Accepted answer: Within our data set, the lowest CLSD historical earnings result was set in Q3 2018, when Clearside Biomedical posted results of -11.250/share. The smallest revenue quarter within our data set was Q3 2018 when Clearside Biomedical reported revenue of NA.

On this page we presented the CLSD historical earnings date information for Clearside Biomedical. Reviewing that Clearside Biomedical Historical Earnings for the company, we see that the highest historical earnings result in our data set was in Q4 2021, when CLSD posted gaap of 4.650/share. Meanwhile the lowest CLSD historical earnings result was in Q3 2018, when CLSD posted gaap of -11.250/share. Moving to Clearside Biomedicals historical revenue numbers, the largest revenue quarter in our data set was seen in Q4 2021 when CLSD reported 0.03B in revenue, while the smallest revenue quarter was Q3 2018 when CLSD reported NA in revenue.

For self directed investors doing their due diligence on CLSD or any other given stock, their research can benefit from looking into all of the Clearside Biomedical historical earnings in our data set presented side by side on one page for ease of comparison. Reviewing this historical EPS information can help when projecting future earnings per share, as well as providing important context for pondering whether the historical earnings trajectory justifies the current stock value or not. That's why we bring you HistoricalEarnings.com to make it more convenient for investors to look into Clearside Biomedical historical earnings, or the historical earnings information for any stock in our coverage universe. In your continued due diligence investigations, we hope you check out the further links included for historical PE studies, earnings surprises history as well as next earnings dates for CLSD. Thanks for visiting, and the next time you need to research CLSD historical earnings or those of another stock, we hope our site will come to your mind as your preferred historical earnings, revenue, and EPS research resource of choice.

Recommended: GLTA Options Chain, IMG Insider Buying, HOFV Split History.

 

Clearside Biomedical Historical Earnings | www.HistoricalEarnings.com | Copyright © 2020 - 2025, All Rights Reserved

Nothing in HistoricalEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 7.6%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 7.6%.